|
Infusystem Holdings Inc (INFU) |
|
Price: $6.9300
$0.25 
3.743%
|
| Day's High:
| $6.95
| Week Perf:
| -3.35 %
|
| Day's Low: |
$ 6.66 |
30 Day Perf: |
7.11 % |
| Volume (M): |
31 |
52 Wk High: |
$ 10.99 |
| Volume (M$): |
$ 217 |
52 Wk Avg: |
$8.13 |
| Open: |
$6.69 |
52 Wk Low: |
$5.74 |
|
|
| Market Capitalization (Millions $) |
150 |
| Shares
Outstanding (Millions) |
22 |
| Employees |
348 |
| Revenues (TTM) (Millions $) |
129 |
| Net Income (TTM) (Millions $) |
0 |
| Cash Flow (TTM) (Millions $) |
0 |
| Capital Exp. (TTM) (Millions $) |
1 |
Infusystem Holdings Inc
Infusystem Holdings Inc is a publicly traded healthcare company that specializes in providing infusion services and products to patients across North America. The company was founded in 1989 and is headquartered in Madison Heights, Michigan. Infusystem Holdings Inc operates through two main subsidiaries: InfuSystem, Inc and Ciscura Holdings, Inc.
InfuSystem, Inc is a leading provider of infusion pumps and related services to patients in the United States. The company offers rental, sales, and service of medical equipment that include infusion pumps, medical carts, and accessories. InfuSystem's clients include hospitals, medical clinics, and home infusion providers. The company's Rental & Sales segment provides rental, sales, and service of ambulatory infusion pumps and ancillary equipment, while its Specialty Pharmacy segment provides comprehensive services to patients and physicians, including distribution of medication and clinical educational support.
Ciscura Holdings, Inc is a provider of specialty infusion services that serve patients with chronic conditions. The company offers a range of in-home infusion therapy solutions, including chemotherapy, pain management, nutrition support, and antibiotic and antiviral therapy. Its services are provided by experienced clinical pharmacists and registered nurses in the patient's home, facilitating improved quality of life and clinical outcomes.
Infusystem Holdings Inc has a strong network of partners and suppliers, which enables it to provide a wide range of products and services to its patients. The company has secure, web-based software platforms and proprietary software systems that make it easy for customers to track patient information, manage equipment rentals and ensure timely delivery of supplies.
The company's stock is publicly traded on the New York Stock Exchange under the symbol INFU. Its market capitalization as of 2021 is approximately $388 million. Infusystem Holdings Inc has a dedicated team of professionals who are committed to providing the best possible care to its patients, which has helped it become one of the leading providers of infusion services in North America.
Company Address: 3851 West Hamlin Road Rochester Hills 48309 MI
Company Phone Number: 291-1210 Stock Exchange / Ticker: NYSEAMER INFU
|
|
| Infusystem Holdings Inc
Infusystem Holdings Inc, a company specializing in infusion therapy services, reported disappointing financial results for the first quarter of 2024 earnings season. The company's loss per share increased significantly to $-0.05, compared to $-0.02 in the same period last year and a significant drop from $0.00 per share in the prior reporting season. This indicates a worrying trend of increasing losses for the company.
Furthermore, despite a slight increase in revenue by 5.351% to $32.00 million, the company still experienced a net loss of $-1.112 million for the quarter, a significant increase from the $-0.324 million loss a year ago. This indicates that the company is struggling to control its expenses and improve its profitability.
|
| Infusystem Holdings Inc
Infusystem Holdings Inc, a medical equipment and supplies company, has shown positive growth and profitability in its fiscal second quarter of 2023, according to their latest financial report.
The company reported a significant turnaround in profitability, with earnings per share (EPS) of $0.02 compared to a loss per share of $-0.01 in the previous year. Meanwhile, income per share improved from a loss of $-0.02 to a positive value. This positive trend in earnings has been reflective of the company's overall revenue growth, which rose by an extensive 17.354% to $31.74 million, compared to $27.04 million in the same period last year. Sequentially, revenue also surged by 4.495% from $30.37 million.
|
| Infusystem Holdings Inc
Infusystem Holdings Inc.: A Growing Company with a Bright Future
Infusystem Holdings Inc. has recently reported an impressive revenue growth of 13.478% for the financial period ending on March 31, 2023. This growth has been achieved despite reporting a net loss of $-0.02 per share. While the company's earnings from the previous reporting season saw a revenue growth of 5.342% from $28.83 million to $30.37 million, the earnings per share remained unchanged at $0.00.
Despite the net loss, Infusystem Holdings Inc. managed to report a higher return on asset (ROA) of 0.06%, compared to its average return on assets of 0.01%. Moreover, it is worth noting that the company was able to improve its ROA compared to the previous quarter, demonstrating that the company is on a path of steady growth and profitability.
|
| |
| Patient Services |
|
 60.08 % |
of total Revenue |
| Device Solutions Transferred over Time |
|
25.05 % |
of total Revenue |
| Patient Services And Device Solutions |
|
79.18 % |
of total Revenue |
| Product Sales Patient Services Transferred at Point in Time |
|
2.17 % |
of total Revenue |
| Product Sales Device Solutions Transferred at Point in Time |
|
11.7 % |
of total Revenue |
| Third-Party Payer Rentals Patient Services Transferred at Point in Time |
|
10.97 % |
of total Revenue |
| Third-Party Payer Rentals Patient Services Transferred over Time |
|
35.28 % |
of total Revenue |
| Direct Payer Rentals Patient Services Transferred over Time |
|
5.72 % |
of total Revenue |
| Service Device Solutions Transferred at Point in Time |
|
7.29 % |
of total Revenue |
| Service Device Solutions Transferred over Time |
|
6.05 % |
of total Revenue |
| Service Device Solutions Transferred over Time Revenue from Contract with Customer Benchmark Customer Concentration Risk |
|
0 % |
of total Revenue |
| Corporate and Eliminations |
|
-5.17 % |
of total Revenue |
| Device Solutions |
|
45.09 % |
of total Revenue |
| Revenue Benchmark Customer Concentration Risk |
|
0 % |
of total Revenue |
| Patient Services Revenue from Contract with Customer Benchmark Customer Concentration Risk |
|
0 % |
of total Revenue |
| Patient Services Revenue Benchmark Customer Concentration Risk |
|
0 % |
of total Revenue |
| Device Solutions Revenue Benchmark Customer Concentration Risk |
|
0 % |
of total Revenue |
| Device Solutions Transferred over Time Revenue from Contract with Customer Benchmark Customer Concentration Risk |
|
0 % |
of total Revenue |
| Patient Services And Device Solutions Revenue from Contract with Customer Benchmark Customer Concentration Risk |
|
0 % |
of total Revenue |
| Patient Services And Device Solutions Revenue Benchmark Customer Concentration Risk |
|
0 % |
of total Revenue |
| Product Sales Patient Services Transferred at Point in Time Revenue from Contract with Customer Benchmark Customer Concentration Risk |
|
0 % |
of total Revenue |
| Product Sales Device Solutions Transferred at Point in Time Revenue from Contract with Customer Benchmark Customer Concentration Risk |
|
0 % |
of total Revenue |
| Third-Party Payer Rentals Patient Services Transferred at Point in Time Revenue from Contract with Customer Benchmark Customer Concentration Risk |
|
0 % |
of total Revenue |
| Third-Party Payer Rentals Patient Services Transferred over Time Revenue from Contract with Customer Benchmark Customer Concentration Risk |
|
0 % |
of total Revenue |
| Direct Payer Rentals Patient Services Transferred over Time Revenue from Contract with Customer Benchmark Customer Concentration Risk |
|
0 % |
of total Revenue |
| Service Device Solutions Transferred at Point in Time Revenue from Contract with Customer Benchmark Customer Concentration Risk |
|
0 % |
of total Revenue |
| Revenue Benchmark Customer Concentration Risk |
|
0 % |
of total Revenue |
| Patient Services Revenue from Contract with Customer Benchmark Customer Concentration Risk |
|
0 % |
of total Revenue |
| Patient Services Revenue Benchmark Customer Concentration Risk |
|
0 % |
of total Revenue |
| Device Solutions Revenue Benchmark Customer Concentration Risk |
|
0 % |
of total Revenue |
| Device Solutions Transferred over Time |
|
25.05 % |
of total Revenue |
| Device Solutions Transferred over Time Revenue from Contract with Customer Benchmark Customer Concentration Risk |
|
0 % |
of total Revenue |
| Patient Services And Device Solutions Revenue from Contract with Customer Benchmark Customer Concentration Risk |
|
0 % |
of total Revenue |
| Patient Services And Device Solutions Revenue Benchmark Customer Concentration Risk |
|
0 % |
of total Revenue |
| Product Sales Patient Services Transferred at Point in Time |
|
2.17 % |
of total Revenue |
| Product Sales Patient Services Transferred at Point in Time Revenue from Contract with Customer Benchmark Customer Concentration Risk |
|
0 % |
of total Revenue |
| Product Sales Device Solutions Transferred at Point in Time |
|
11.7 % |
of total Revenue |
| Product Sales Device Solutions Transferred at Point in Time Revenue from Contract with Customer Benchmark Customer Concentration Risk |
|
0 % |
of total Revenue |
| Third-Party Payer Rentals Patient Services Transferred at Point in Time |
|
10.97 % |
of total Revenue |
| Third-Party Payer Rentals Patient Services Transferred at Point in Time Revenue from Contract with Customer Benchmark Customer Concentration Risk |
|
0 % |
of total Revenue |
| Third-Party Payer Rentals Patient Services Transferred over Time |
|
35.28 % |
of total Revenue |
| Third-Party Payer Rentals Patient Services Transferred over Time Revenue from Contract with Customer Benchmark Customer Concentration Risk |
|
0 % |
of total Revenue |
| Direct Payer Rentals Patient Services Transferred over Time |
|
5.72 % |
of total Revenue |
| Direct Payer Rentals Patient Services Transferred over Time Revenue from Contract with Customer Benchmark Customer Concentration Risk |
|
0 % |
of total Revenue |
| Service Device Solutions Transferred at Point in Time |
|
7.29 % |
of total Revenue |
| Service Device Solutions Transferred at Point in Time Revenue from Contract with Customer Benchmark Customer Concentration Risk |
|
0 % |
of total Revenue |
| Service Device Solutions Transferred over Time |
|
6.05 % |
of total Revenue |
| Service Device Solutions Transferred over Time Revenue from Contract with Customer Benchmark Customer Concentration Risk |
|
0 % |
of total Revenue |
